"10.1371_journal.pone.0087257","plos one","2014-01-28T00:00:00Z","Eric Mick; James McGough; Curtis K Deutsch; Jean A Frazier; David Kennedy; Robert J Goldberg","Department of Quantitative Health Sciences and the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Division of Child and Adolescent Psychiatry, University of California, Los Angeles Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, Los Angeles California, United States of America; Eunice Kennedy Shriver Center, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Psychiatry Department, Division of Child and Adolescent Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Psychiatry Department, Division of Neuroinformatics and the Child and Adolescent NeuroDevelopment Initiative, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America","Conceived and designed the experiments: EM JM CD RG. Analyzed the data: EM. Wrote the paper: EM JM CD JF DK RG.","Dr. McGough receives grant or research support from the National Institutes of Health, NeuroSigma Inc., and Shire Pharmaceuticals. He has served as a consultant to Akili Interactive, Inc., Sunovion Pharmaceuticals, Targacept, and Theravance. Dr. Frazier receives or has received research funding from or participates in clinical trials with Bristol-Myers Squibb, Glaxo Smith Kline, Pfizer, Inc. and Seaside Therapeutics. All other authors have no disclosures. This disclosure does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Eric Mick","EM",6,TRUE,4,NA,1,6,TRUE,TRUE,FALSE,0,NA,FALSE
